DTIL · NASDAQ
Precision BioSciences (DTIL) Stock Price & Fundamentals
Precision BioSciences (DTIL) closed at $606.49 on Oct 9, 2026, down 0.95% from the previous close of $612.29.
Share price, past year
1Y +17.10%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $606.49 |
| Sep 30, 2026 | $635.29 |
| Aug 31, 2026 | $638.53 |
| Jul 31, 2026 | $628.43 |
| Jun 30, 2026 | $603.94 |
| May 29, 2026 | $565.21 |
| Apr 30, 2026 | $525.40 |
| Mar 31, 2026 | $527.60 |
| Feb 27, 2026 | $523.21 |
| Jan 30, 2026 | $534.59 |
| Dec 31, 2025 | $500.97 |
| Nov 28, 2025 | $506.07 |
| Oct 31, 2025 | $548.96 |
Key statistics
- Market cap
- $16.03B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.23
- Revenue (TTM)
- $45.06M
- Net income (TTM)
- −$52.73M
- Shares outstanding
- 26.4M
- Dividend yield
- —
- 52-week range
- $488.26 – $646.76
Precision BioSciences's market cap is $16.03B, based on a share price of $606.49 and 26.4M shares outstanding as of Jun 30, 2026.
Financials
Precision BioSciences reported revenue of $34.26M for fiscal 2025, down 50.12% from fiscal 2024.
Precision BioSciences reported a net loss of $45.72M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $34.26M | −50.1% | −$45.72M | −133.5% | −$3.56 | — |
| FY2024ended Dec 31, 2024 | $68.70M | +41.0% | $7.17M | 10.4% | $1.04 | — |
| FY2023ended Dec 31, 2023 | $48.73M | +94.2% | −$61.32M | −125.8% | −$15.96 | — |
| FY2022ended Dec 31, 2022 | $25.10M | −78.3% | −$111.64M | −444.8% | −$38.10 | — |
| FY2021ended Dec 31, 2021 | $115.53M | +375.7% | −$30.60M | −26.5% | −$0.52 | — |
| FY2020ended Dec 31, 2020 | $24.29M | −97.7% | −$109.01M | −448.9% | −$2.09 | — |
| FY2019ended Dec 31, 2019 | $1.07B | +9,731.9% | −$92.88M | −8.7% | −$2.21 | — |
| FY2018ended Dec 31, 2018 | $10.88M | — | −$46.04M | −423.0% | −$2.92 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $0.00 | −$32.65M | −$1.26 |
| Q1 FY2026ended Mar 31, 2026 | $10.84M | −$18.44M | −$0.75 |
| Q4 FY2025ended Dec 31, 2025 | $34.20M | $20.13M | $2.62 |
| Q3 FY2025ended Sep 30, 2025 | $13.00K | −$21.77M | −$1.84 |
| Q2 FY2025ended Jun 30, 2025 | $18.00K | −$23.52M | −$2.13 |
| Q1 FY2025ended Mar 31, 2025 | $29.00K | −$20.57M | −$2.21 |
| Q4 FY2024ended Dec 31, 2024 | $638.00K | −$17.75M | −$3.08 |
| Q3 FY2024ended Sep 30, 2024 | $576.00K | −$16.43M | −$2.25 |
Company profile
- Name
- Precision BioSciences, Inc.
- Ticker
- DTIL
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 302 East Pettigrew Street, Suite A-100, Durham, NC 27701
- Incorporated in
- DE
- Fiscal year ends
- May
- SEC CIK
- 0001357874
Recent SEC filings
- Aug 24, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 27, 2026
- Jul 1, 2026
- Jun 16, 2026
- May 27, 2026
- May 26, 2026
Frequently asked questions
What is Precision BioSciences's stock price?
Precision BioSciences (DTIL) closed at $606.49 on Oct 9, 2026, down 0.95% from the previous close of $612.29.
What is Precision BioSciences's market cap?
Precision BioSciences's market cap is $16.03B, based on a share price of $606.49 and 26.4M shares outstanding as of Jun 30, 2026.
How much revenue does Precision BioSciences make?
Precision BioSciences reported revenue of $34.26M for fiscal 2025, down 50.12% from fiscal 2024.
Does Precision BioSciences pay a dividend?
Precision BioSciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Precision BioSciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures